Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma

BACKGROUND: TP53 is frequently altered in esophageal squamous cell carcinoma (ESCC). However, the landscape of TP53 mutation and its effects on patients remain controversial. METHODS: Somatic mutations of TP53 in 161 patients with resectable ESCC were identified by next-generation sequencing (NGS) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Minran, Jin, Jiaoyue, Zhang, Fanrong, Wu, Yingxue, Xu, Chenyang, Ying, Lisha, Su, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186752/
https://www.ncbi.nlm.nih.gov/pubmed/32355760
http://dx.doi.org/10.21037/atm.2020.02.142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186752/
https://www.ncbi.nlm.nih.gov/pubmed/32355760
http://dx.doi.org/10.21037/atm.2020.02.142

Ejemplares similares